---
title: "Simvastatin - Mixed hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db00641-mesh-d006950-1.html
toc: false 
---


Path ID: `DB00641_MESH_D006950_1`
{% include image.html url="images/db00641-mesh-d006950-1.png" file="db00641-mesh-d006950-1.png" alt="db00641-mesh-d006950-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| MESH:D019821 | Simvastatin | Drug |
| UniProt:P04035 | HMG-CoA reductase | Protein |
| REACT:R-HSA-191273 | Cholesterol synthesis | Pathway |
| REACT:R-HSA-8866423 | Very low density lipoprotein (VLDL) synthesis | Pathway |
| MESH:D002784 | Cholesterol | ChemicalSubstance |
| MESH:D008077 | Low density lipoprotein-cholesterol (LDL-C) | ChemicalSubstance |
| MESH:D006950 | Mixed hyperlipidemia | Disease |
|------------|------|---------|

## Relationships

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Simvastatin | DECREASES ACTIVITY OF | Hmg-Coa Reductase |
| Hmg-Coa Reductase | NEGATIVELY REGULATES | Cholesterol Synthesis |
| Cholesterol Synthesis | DECREASES ABUNDANCE OF | Cholesterol |
| Hmg-Coa Reductase | NEGATIVELY REGULATES | Very Low Density Lipoprotein (Vldl) Synthesis |
| Very Low Density Lipoprotein (Vldl) Synthesis | DECREASES ABUNDANCE OF | Low Density Lipoprotein-Cholesterol (Ldl-C) |
| Low Density Lipoprotein-Cholesterol (Ldl-C) | CONTRIBUTES TO | Mixed Hyperlipidemia |
| Cholesterol | CONTRIBUTES TO | Mixed Hyperlipidemia |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00641#mechanismofaction](https://go.drugbank.com/drugs/DB00641#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin](https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin)

Reference: 
  - [https://go.drugbank.com/drugs/DB00641#mechanismofaction](https://go.drugbank.com/drugs/DB00641#mechanismofaction)
  - [https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin](https://pubchem.ncbi.nlm.nih.gov/compound/Simvastatin)
